[January 23, 2015]

Research and Markets: Bladder Cancer: Disease and Pipeline Analysis Report

Research and Markets (http://www.researchandmarkets.com/research/3b2sxr/bladder_cancer) has announced the addition of the "Bladder Cancer: Disease and Pipeline Analysis" report to their offering.

This report offers an in-depth market and pipeline analysis of the bladder cancer market. This unique therapeutic assessment provides an overview of the current and future bladder cancer clinical development market, the activities of the key market players, and an outline of trial and commercial regulatory environments.

The latest figures from the World Health Organization show that bladder cancer has a worldwide incidence of almost 430,000 diagnosed cases per year. This constitutes 3.1% of cancer incidence, making it the 9th most commonly diagnosed cancer globally, explained Andrew Schaer, President of ISR. There are currently more than 100 active clinical trials for bladder cancer, making this a very dynamic clinical development space.

How you can use this report:

- Identify and enhance commercial and development opportunities with an in-depth analysis of the global bladder cancer market including global and country-specific incidence rates for bladder cancer

- Plan how products currently in development could impact this market and understand competitor involvement

- Plan your clinical trial strategy better by understanding the clinical trial environment across countries

Report Structure:

- Disease Overview

- Bladder Cancer Epidemiology

- Bladder Cancer Diagnosis and Staging

- Bladder Tumour Classification

- Treatment of Bladder Cancer

- Bladder Cancer Prognosis (News - Alert)

- Environmental Analysis

- Drug Development in Bladder Cancer

This Bladder Cancer report provides:

- Insight into bladder cancer epidemiology

- Incidence and mortality rates in both major and emerging markets

- A look into the current treatments for bladder cancer by disease stage and therapy type

- An environmental analysis of the major and emerging markets by:

- Patient Population and Product Environment

- Trial and Recruitment Environment

- Regulatory Environment

- Competitive Product Landscape

- Pricing and Reimbursement Environment

- A unique view into new therapies in active development

For more information visit http://www.researchandmarkets.com/research/3b2sxr/bladder_cancer

[ Back To TMCnet.com's Homepage ]